Droxidopa for the treatment of neurogenic orthostatic hypotension and other symptoms of neurodegenerative disorders

Hemodynamic Effects of l-Threo-3,4-Dihydroxyphenylserine (Droxidopa) in Hypotensive Individuals With Spinal Cord Injury

(2013) Jill M. Wecht et al.   ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION

Emerging drugs for autonomic dysfunction in Parkinson's disease

(2013) Santiago Perez-Lloret et al.   EXPERT OPINION ON EMERGING DRUGS

European Society of Hypertension Position Paper on Ambulatory Blood Pressure Monitoring

(2013) Eoin O’Brien et al.   JOURNAL OF HYPERTENSION

Efficacy of treatments for orthostatic hypotension: a systematic review

(2012) Ian C. Logan et al.   AGE AND AGEING

L-Threo-Dihydroxyphenylserine corrects neurochemical abnormalities in a menkes disease mouse model

(2012) Anthony Donsante et al.   ANNALS OF NEUROLOGY

Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats

(2012) Mar Coll et al.   HEPATOLOGY

Dopamine Dysregulation Syndrome Including Mania Related to Coadministration of Droxidopa

(2012) Shinnosuke Saito et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

L-threo-3,4-dihydroxyphenylserine (L-DOPS) co-administered with entacapone improves freezing of gait in Parkinson’s disease

(2012) Kei Fukada et al.   MEDICAL HYPOTHESES

Brain monoamine systems in multiple system atrophy: A positron emission tomography study

(2012) Stephanie J. Lewis et al.   NEUROBIOLOGY OF DISEASE

Factors related to orthostatic hypotension in Parkinson's disease

(2012) Santiago Perez-Lloret et al.   PARKINSONISM & RELATED DISORDERS

Non-pharmacological treatments for orthostatic hypotension

(2011) P. Thompson et al.   AGE AND AGEING

Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome

(2011) Roy Freeman et al.   AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL

Orthostatic Hypotension Is Differentially Associated with the Cerebellar Versus the Parkinsonian Variant of Multiple System Atrophy: a Comparative Study

(2011) Gregor Karl Wenning et al.   CEREBELLUM

Cardiovascular autonomic dysfunction in MSA and Parkinson's disease: Similarities and differences

(2011) Valeria Iodice et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension

(2011) Anne Pavy-Le Traon et al.   MOVEMENT DISORDERS

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

(2011) Klaus Seppi et al.   MOVEMENT DISORDERS

The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease

(2011) Sergey Kalinin et al.   NEUROBIOLOGY OF AGING

The prevalence of symptomatic orthostatic hypotension in patients with Parkinson’s disease and atypical parkinsonism

(2011) Ainhi D. Ha et al.   PARKINSONISM & RELATED DISORDERS

Pharmacotherapy of autonomic failure

(2011) Cyndya Shibao et al.   PHARMACOLOGY & THERAPEUTICS

Contamination of the Norepinephrine Prodrug Droxidopa by Dihydroxyphenylacetaldehyde

(2010) C. Holmes et al.   CLINICAL CHEMISTRY

Comparative Efficacy of Yohimbine Against Pyridostigmine for the Treatment of Orthostatic Hypotension in Autonomic Failure

(2010) Cyndya Shibao et al.   HYPERTENSION

Effects of Carbidopa and Entacapone on the Metabolic Fate of the Norepinephrine Prodrug L-DOPS

(2010) David S. Goldstein et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Abnormal cardiac [123I]-meta-iodobenzylguanidine uptake in multiple system atrophy

(2010) Hiroshi Nagayama et al.   MOVEMENT DISORDERS

The association between orthostatic hypotension and medication use in the British Women's Heart and Health Study

(2009) S. Kamaruzzaman et al.   AGE AND AGEING

Tilt testing and neurally mediated syncope: too many protocols for one condition or specific protocols for different situations?

(2009) A. Moya   EUROPEAN HEART JOURNAL

Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project)

(2009) A. Fedorowski et al.   EUROPEAN HEART JOURNAL

Are current recommendations to diagnose orthostatic hypotension in Parkinson's disease satisfactory?

(2009) Jenny Jamnadas-Khoda et al.   MOVEMENT DISORDERS

Baroreflex sensitivity and power spectral analysis during autonomic testing in different extrapyramidal syndromes

(2009) Constanze Friedrich et al.   MOVEMENT DISORDERS

L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension

(2008) Christopher J. Mathias   CLINICAL AUTONOMIC RESEARCH

Prevalence of orthostatic hypotension

(2008) Phillip A. Low   CLINICAL AUTONOMIC RESEARCH

L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension

(2008) Horacio Kaufmann   CLINICAL AUTONOMIC RESEARCH

Adrenergic supersensitivity in Parkinsonians with orthostatic hypotension

(2008) J. M. SENARD et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Orthostatic Hypotension and Risk of Cardiovascular Disease in Elderly People: The Rotterdam Study

(2008) Germaine C. Verwoert et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Management of neurogenic orthostatic hypotension: an update

(2008) Phillip A Low et al.   LANCET NEUROLOGY

Neurogenic Orthostatic Hypotension

(2008) Roy Freeman   NEW ENGLAND JOURNAL OF MEDICINE

Cardiac denervation occurs independent of orthostatic hypotension and impaired heart rate variability in Parkinson's disease

(2008) C.-A. Haensch et al.   PARKINSONISM & RELATED DISORDERS

Nocturnal hypertension defined by fixed cut-off limits is a better predictor of left ventricular hypertrophy than non-dipping

(2007) Santiago Perez-Lloret et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Myocardial123metaiodobenzylguanidine uptake in genetic Parkinson's disease

(2007) Aldo Quattrone et al.   MOVEMENT DISORDERS